HOME >> MEDICINE >> NEWS
Brain power combined to form new $125M institute

In an effort to discover better treatments for brain disorders and create one of the world's top 10 neuroscience research institutes, the Howard Florey Institute, Brain Research Institute and the National Stroke Research Institute will amalgamate to form a new neuroscience institute in Melbourne.

As part of the Victorian Government funded project, the Mental Health Research Institute has decided to move from its current premises to co-locate with the yet to be named new institute.

The project to merge and co-locate will receive $53 million from the Victorian Government, which will help fund the construction of new facilities at the University of Melbourne's Parkville campus and at the Austin Hospital in Heidelberg.

The entire project is estimated to cost over $125 million and the participants in the new institute are currently seeking further financial support from philanthropists.

The new institute will focus on major brain and mind disorders including stroke, epilepsy, multiple sclerosis, dementia, Parkinson's disease, addiction, schizophrenia and mood disorders.

The Director's of the four Institutes are delighted with the Victorian Government's commitment to further develop neuroscience research in Melbourne.

Director of the Howard Florey Institute, Professor Frederick Mendelsohn AO said, "We are proud to partner with the Victorian Government in this ambitious venture that will help reinforce Melbourne's position as Australia's medical research capital."

Director of the Brain Research Institute, Professor Graeme Jackson said, "By joining forces with other leading neuroscience institutes, we hope to unravel the secrets of the brain and find better treatments for the millions of Australians affected by brain disorders every year."

Director of the National Stroke Research Institute, Professor Geoffrey Donnan said, "Combining our talents will also help us attract outstanding scientists from around the wo
'"/>

Contact: Merrin Rafferty
61-383-441-658
Research Australia
3-Apr-2006


Page: 1 2

Related medicine news :

1. Brain-boosting pill alleviates post-chemotherapy fogginess
2. Brain inflammation may be friend, not foe, for Alzheimers patients
3. Brain activity reflects differences in types of anxiety
4. Brain research poised to dramatically advance global society
5. Elsevier announces launch of Brain Stimulation
6. Brains scans of symptomatic Gulf War veterans show differences
7. Brain structure changes years before memory loss begins
8. Brain studies reveal the mechanisms of the voluntary control of visual attention
9. Brains can recover from alcoholic damage but patients should stop drinking as soon as possible
10. Brain images show hysteria not an imaginary disorder
11. Brain changes in patients with migraine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brain power combined form new institute

(Date:5/21/2013)... The National Resident Matching Program NRMP® ... its Board of Directors. Hal B. Jenson, M.D., ... of Medicine, has been named President. Maria C. ... of California San Diego, is the President-Designate, and Glenn ... Medical Center, is the Secretary-Treasurer. Kenneth B. Simons, ...
(Date:5/21/2013)... Dr. James C. Wittig, Chief of ... Sarcoma Division of the John Theurer Cancer Center at ... named one of the top 13 Orthopedic Oncologists in ... Wittig is one of approximately 125 surgeons in America ... by surveying thought leaders in the field of Oncology. ...
(Date:5/21/2013)... 21, 2013 Brunswick Laboratories, Inc. ... the development and standardization of validated analytical methods, ... Brunswick Laboratories and the USDA, as a First ... This decision comes after extensive review by an ... Harnly of the U.S. Department of Agriculture. , ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3
(Date:5/21/2013)... 2013 Ceregene, Inc. today announced additional ... double-blind, randomized, controlled Phase 2b clinical study of ... designed to deliver the neurotrophic factor neurturin, for ... robust response to CERE-120 in Parkinson,s patients diagnosed ... those diagnosed 10 years or more (p<.005), as ...
(Date:5/20/2013)... , May 21, 2013 ... Assembly, where world,s health ministers gather to address the ... Mental and neurological disorders (MNDs) affect 700 million ... non-communicable disease (NCD) burden ,Do You Mind?, ... the role each can play to collectively address MNDs ...
(Date:5/20/2013)... May 20, 2013 The Board of ... companies include OMNIlife science®, Inc., Enztec, Ltd., and Praxim, ... Board.  Guy Mayer , an ... of the Board of Directors and David Johnson, an ... director. Before joining OSI as Board ...
Breaking Medicine Technology:Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 2Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors 3
Cached News: